Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study

NCT04893031 is registered in ClinicalTrials.gov with Karadeniz Technical University as lead sponsor.

NCT NCT04893031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04893031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study
Lead sponsor
Karadeniz Technical University
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
April 1, 2021
Enrollment
213 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, critical care, mortality, tocilizumab